Recent Trends in Cardiovascular Disease Mortality in Kazakhstan

Overview

Journal Vasc Health Risk Manag

Publisher Dove Medical Press

Specialty Cardiology & Vascular Diseases

Date 2023 Aug 30

PMID 37645218

Authors

Gulnara Junusbekova

Meiramgul Tundybayeva

Nazgul Akhtaeva

Lyazzat Kosherbayeva

Affiliations

Soon will be listed here.

Abstract

Introduction: Cardiovascular diseases (CVD) are the leading cause of mortality in Kazakhstan. In the last decade, Kazakhstan has carried out a number of reforms in the healthcare sector, in particular, to reduce mortality from significant diseases, including CVD. This study aimed to provide the trend of avoidable mortality from CVD in Kazakhstan.

Methods: We extracted data from the Bureau of National Statistics of the Agency for Strategic Planning and Reforms of the Republic of Kazakhstan on population by age; mortality rates from chronic rheumatic heart disease (I05-I09); hypertensive diseases (I10-I15); ischaemic heart disease (I20-I25); cerebrovascular diseases (I60-I69) from 2011 to 2021, by gender and 5-year age group (0, 1-4, 5-9, 74). We applied join point regression to calculate the average annual percentage change (AAPC). In addition, crude mortality and trends were calculated per 100,000 population.

Results: The avoidable mortality rates, including treatable and preventable mortality decreased between 2011 and 2019 and then increased in the last two years (2020 and 2021) in all four studied disease groups. The AAPC showed that total avoidable mortality rates decreased between 2011 and 2021-6.0 points (-10.6 to - 1.1) (p = 0.017), whereas in males -4.2 (-8.3 to 0.1) and females - 5.1 (-8.8 to -1.3) (p = 0.009). Avoidable mortality rates from ischemic heart disease, cerebrovascular and hypertensive disease has been reduced stronger in male compared to female. The crude mortality declined over the period given; however, among young people mortality is still high.

Discussion: Our findings showed that avoidable mortality from CVD decreased over the last years, which could be related to the policy on strengthening the primary care on early diagnosis and detection of CVD and its risk factors. However, primary healthcare facilities need to improve activities on health literacy (drug adherence, risk factors) of the population, including the prevention of CVD.

Citing Articles

Mortality Rate from Circulatory Diseases, Ischemic Heart Disease and Cerebrovascular Diseases in Serbia, 1998-2021.

Stepovic M, Jovanovic K, Milosavljevic J, Tepavcevic M, Radovanovic J, Selakovic V Iran J Public Health. 2025; 53(12):2722-2729.

PMID: 39759192 PMC: 11693801.

References

Uthman O, Al-Khudairy L, Nduka C, Court R, Mistry H, Melendez-Torres G . Determining optimal strategies for primary prevention of cardiovascular disease: systematic review, cost-effectiveness review and network meta-analysis protocol. Syst Rev. 2020; 9(1):105. PMC: 7204030. DOI: 10.1186/s13643-020-01366-x. View

Roth G, Johnson C, Abajobir A, Abd-Allah F, Abera S, Abyu G . Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015. J Am Coll Cardiol. 2017; 70(1):1-25. PMC: 5491406. DOI: 10.1016/j.jacc.2017.04.052. View

Shayakhmetov S, Toguzbayeva K, Ismailova A, Tabibi R, Derbishalieva Z, Dzhusupov K . Health Literacy of Rural Population of Kazakhstan. Iran J Public Health. 2020; 49(7):1269-1277. PMC: 7548489. DOI: 10.18502/ijph.v49i7.3580. View

Movsisyan N, Vinciguerra M, Medina-Inojosa J, Lopez-Jimenez F . Cardiovascular Diseases in Central and Eastern Europe: A Call for More Surveillance and Evidence-Based Health Promotion. Ann Glob Health. 2020; 86(1):21. PMC: 7059421. DOI: 10.5334/aogh.2713. View

Sidney S, Lee C, Liu J, Khan S, Lloyd-Jones D, Rana J . Age-Adjusted Mortality Rates and Age and Risk-Associated Contributions to Change in Heart Disease and Stroke Mortality, 2011-2019 and 2019-2020. JAMA Netw Open. 2022; 5(3):e223872. PMC: 8943624. DOI: 10.1001/jamanetworkopen.2022.3872. View

Aringazina A, Kuandikov T, Arkhipov V . Burden of the Cardiovascular Diseases in Central Asia. Cent Asian J Glob Health. 2019; 7(1):321. PMC: 6393056. DOI: 10.5195/cajgh.2018.321. View

Sheiman I . Rocky road from the Semashko to a new health model. Interview by Fiona Fleck. Bull World Health Organ. 2013; 91(5):320-1. PMC: 3646351. DOI: 10.2471/BLT.13.030513. View

Wilson L, Bhatnagar P, Townsend N . Comparing trends in mortality from cardiovascular disease and cancer in the United Kingdom, 1983-2013: joinpoint regression analysis. Popul Health Metr. 2017; 15(1):23. PMC: 5494138. DOI: 10.1186/s12963-017-0141-5. View

Walli-Attaei M, Joseph P, Rosengren A, Chow C, Rangarajan S, Lear S . Variations between women and men in risk factors, treatments, cardiovascular disease incidence, and death in 27 high-income, middle-income, and low-income countries (PURE): a prospective cohort study. Lancet. 2020; 396(10244):97-109. DOI: 10.1016/S0140-6736(20)30543-2. View

10.

Lee S, Kim H, Lee H, Suh I . Thirty-year trends in mortality from cardiovascular diseases in Korea. Korean Circ J. 2015; 45(3):202-9. PMC: 4446814. DOI: 10.4070/kcj.2015.45.3.202. View

11.

Gheorghe A, Griffiths U, Murphy A, Legido-Quigley H, Lamptey P, Perel P . The economic burden of cardiovascular disease and hypertension in low- and middle-income countries: a systematic review. BMC Public Health. 2018; 18(1):975. PMC: 6090747. DOI: 10.1186/s12889-018-5806-x. View

12.

Bae S, Kim S, Kim M, Shim W, Park S . Impact of cardiovascular disease and risk factors on fatal outcomes in patients with COVID-19 according to age: a systematic review and meta-analysis. Heart. 2020; 107(5):373-380. DOI: 10.1136/heartjnl-2020-317901. View

13.

Kulkayeva G, Harun-Or-Rashid M, Yoshida Y, Tulebayev K, Sakamoto J . Cardiovascular disease risk factors among rural Kazakh population. Nagoya J Med Sci. 2012; 74(1-2):51-61. PMC: 4831250. View

14.

Rosu M, Oliffe J, Kelly M . Nurse Practitioners and Men's Primary Health Care. Am J Mens Health. 2015; 11(5):1501-1511. PMC: 5675208. DOI: 10.1177/1557988315617721. View

15.

Sharma S, Wood M . The Global Burden of Cardiovascular Disease in Women. Curr Treat Options Cardiovasc Med. 2018; 20(10):81. DOI: 10.1007/s11936-018-0676-1. View

16.

Mukasheva G, Abenova M, Shaltynov A, Tsigengage O, Mussabekova Z, Bulegenov T . Incidence and Mortality of Cardiovascular Disease in the Republic of Kazakhstan: 2004-2017. Iran J Public Health. 2022; 51(4):821-830. PMC: 9288408. DOI: 10.18502/ijph.v51i4.9243. View

17.

Roth G, Mensah G, Johnson C, Addolorato G, Ammirati E, Baddour L . Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update From the GBD 2019 Study. J Am Coll Cardiol. 2020; 76(25):2982-3021. PMC: 7755038. DOI: 10.1016/j.jacc.2020.11.010. View

18.

RUTSTEIN D, BERENBERG W, CHALMERS T, CHILD 3rd C, Fishman A, PERRIN E . Measuring the quality of medical care. A clinical method. N Engl J Med. 1976; 294(11):582-8. DOI: 10.1056/NEJM197603112941104. View

19.

Feller A, Schmidlin K, Clough-Gorr K . Trends and socioeconomic inequalities in amenable mortality in Switzerland with international comparisons. Swiss Med Wkly. 2017; 147:w14478. DOI: 10.4414/smw.2017.14478. View

20.

Davletov K, Mckee M, Berkinbayev S, Battakova Z, Vujnovic M, Rechel B . Regional differences in cardiovascular mortality in Kazakhstan: further evidence for the 'Russian mortality paradox'?. Eur J Public Health. 2015; 25(5):890-4. DOI: 10.1093/eurpub/ckv019. View